🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is — my results so far Page 9

Can we talk about how SLOW the FDA is — my results so far

NurseAsh_DET Tue, Nov 18, 2025 at 7:47 PM 43 replies 1,294 viewsPage 9 of 9
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Apr 26, 2026 at 8:07 AM#41
LabKate said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

No disagreement with LabKate. One condition attached. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

43 16mona_PHX, andrew_nyc, Dr.EndoEP and 40 others
Reply Quote Save Share Report
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
May 3, 2026 at 5:08 AM#42
LabKate said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Sending this to two other people who asked me the same thing last week.

44 17julia.endo, JessicaM_2024, TomFromTexas and 41 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 10, 2026 at 2:06 AM#43

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. Carry on.

Last edited: May 10, 2026 at 6:06 AM
45 18RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 42 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
tane_welly
Member
234
1,123
Sep 2024
Wellington, NZ
May 16, 2026 at 11:00 PM#44
james_edin said:
Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

This is my experience too, for whatever a second data point is worth. Nothing to add that would improve it.

Last edited: May 17, 2026 at 2:00 AM
46 19marco_milano, pam_columbus, nick_SD_fit and 43 others
Reply Quote Save Share Report
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
May 23, 2026 at 7:49 PM#45
james_edin said:
Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

Adding the part of the answer the thread has not reached. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

Last edited: May 23, 2026 at 8:49 PM
47 20TomFromTexas, mike.trainer_LA, sarah_nash92 and 44 others
Reply Quote Save Share Report
1789

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register